Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.
about
Microenvironment abnormalities and lymphomagenesis: Immunological aspects.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Myeloid-derived suppressor cells in B cell malignancies.Premetastatic niche formation in the liver: emerging mechanisms and mouse models.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain.MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.Circulating CD14+ HLA-DR-/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery.Association of Chemokines and Chemokine Receptor Expression with Monocytic-Myeloid-Derived Suppressor Cells during Tumor Progression.Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability
P2860
Q36118020-0E609130-3F51-4B3B-9E8A-3E7DEA9BF15AQ37079141-A1363677-95BB-40E2-A7D7-B57C7378D562Q38578686-7B9AC7C0-89C4-4881-9DC0-15C31AA786C8Q38591967-68A96B85-7C07-4DC4-9F8C-E13E4CDD0B74Q38864758-0899E4D4-0DF4-48DC-A9F6-9EDDCC617426Q38931895-9BE6B4B9-72EC-4FE4-9645-3137E643BAA7Q47325431-B5D72236-1DD5-4604-9DA1-DE31A2CB98C2Q50175409-D995D164-39F0-42BB-A7C4-78E074747034Q50948891-6B24BF39-B092-4D52-8996-DF927ED6F7FAQ51759802-E3275C70-7B88-4390-9416-AC282F595A64Q55516375-05B33320-D23E-4222-833A-EDFC1ADDF640Q58804718-01CDE58D-1DAF-49EC-8E9C-6E8C7A97220B
P2860
Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Characterization of the myeloi ...... K cells in malignant lymphoma.
@ast
Characterization of the myeloi ...... K cells in malignant lymphoma.
@en
type
label
Characterization of the myeloi ...... K cells in malignant lymphoma.
@ast
Characterization of the myeloi ...... K cells in malignant lymphoma.
@en
prefLabel
Characterization of the myeloi ...... K cells in malignant lymphoma.
@ast
Characterization of the myeloi ...... K cells in malignant lymphoma.
@en
P2093
P2860
P1433
P1476
Characterization of the myeloi ...... K cells in malignant lymphoma.
@en
P2093
Fumio Kawano
Jun Shinga
Kanako Shimizu
Kazuhiro Kakimi
Michihiro Hidaka
Miki Asakura
Satoru Yamasaki
Shin-Ichiro Fujii
Yusuke Sato
P2860
P304
P356
10.1080/2162402X.2014.995541
P577
2015-01-22T00:00:00Z